opt-out

In a pivotal legal battle with profound implications, the U.S. Supreme Court heard nearly two hours of oral arguments on Tuesday regarding a case seeking to ban the FDA-approved abortion drug, mifepristone. The majority of justices expressed skepticism toward the arguments presented by the plaintiffs, the Alliance For Hippocratic Medicine, suggesting potential implications for Black…